6-Iodo-4-Hydroxyquinazoline CAS 16064-08-7 Puritas > 98.5% (HPLC) Factory

Description:

Nomen chemicum: 6-Iodo-4-Hydroxyquinazoline

CAS: 16064-08-7

Puritas: >98.5% (HPLC)

Aspectus: Palea Yellow ad Brown Crystal pulveris

Medium API (CAS: 388082-78-8)

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Lapatinib intermedia:

Lapatinib Base	CAS 231277-92-2
Lapatinib Ditosylate Monohydrate	CAS 388082-78-8
Sodium Methanesulfinate	CAS 20277-69-4
3-Chloro-4-(3-Fluorobenzyloxy)aniline	CAS 202197-26-0
2-Aminoethyl Methyl Sulfone Hydrochloridis	CAS 104458-24-4
4-Chloro-6-Iodoquinazoline	CAS 98556-31-1
6-Iodo-4-Hydroxyquinazoline	CAS 16064-08-7
5-Formyl-2-Acidi Furanboronic	CAS 27329-70-0
5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde	CAS 231278-84-5

Chemical Properties:

Nomen chemicum	6-Iodo-4-Hydroxyquinazoline
Synonyma	6-Iodoquinazolin-4-unum;6-Iodo-4-Quinazolinone;6-Iodoquinazolin-4(3H)-one;6-Iodo-4(1H)-Quinazolinone;6-Iodo-4-Quinazolinol
CAS Number	16064-08-7
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C8H5IN2O
M. Pondus	272.04
Liquescens punctum	271℃ (lit.)
Density	2.11±0.10 g/cm3
COA & MSDS	Praesto
Origin	Shanghai, China
Brand	Ruifu Chemical

Specifications:

Item	Specifications	Specifications
Aspectus	Pallida ad Brown Crystal	Obsequitur
Lepidium sativum	H-NMR, MS	Obsequitur
Damnum in Siccatio	<1.00%	0.45%
Residere in Ignition	<0.10%	<0.10%
Puritas / Analysis Methodus	>98.5% (HPLC)	98.79% (HPLC)
1 H NMR Spectrum	Congruunt cum Structure	Obsequitur
Test Standard	Enterprise Standard
Consuetudinem	Medium API (CAS: 388082-78-8)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

16064-08-7 - Periculum et Salus;

Periculum Codes
36 - Ad oculos irritans
Salus Descriptio
XXVI - In contactu cum oculis, statim cum aqua multa accende et quaerere consilium medicinae.

16064-08-7 - Applicatio:

6-Iodo-4-Hydroxyquinazoline (CAS: 16064-08-7) medium est in synthesi API (CAS: 388082-78-8).(CAS: 388082-78-8) praesto est in tabulis 250-mg pro administratione oralis adhibenda in compositione cum Cabecitabine in tractatione cancri pectoris pro iis aegros qui supra expressam speciem 2 EGF-R et qui antea taxatam, anthracyclinam, et trastuzumab justo.Genus 2EGF-R subtypum unum est huius receptoris et quoque notum est asHER2 vel ErbB-2.Agens est receptaculum TK inhibitoris targetingthe ErbB-1 et ErbB-2 subtyporum.